1-5 of 5
Kolja Eppert, MSc, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Single Cell Transcriptomic Analysis of the Histone H3 K27M Mutation in Pre-Leukemic Hematopoietic Stem Cells

Meaghan Boileau, BSc, Selin Jessa, BSc, Samantha Worme, BSc, Damien Faury, Nada Jabado, MD PhD, François Mercier, MD, Claudia Kleinman, PhD, Kolja Eppert, MSc, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3773.
https://doi.org/10.1182/blood-2019-123769
Published: 2019
Journal Articles

Novel Therapeutics That Can Target and Eradicate Leukemic Stem Cells in Acute Myeloid Leukemia: Investigating FDA-Approved Anti-Inflammatory Compounds

Isabella Iasenza, Meaghan Boileau, BSc, Andrea Neumann, BSc., Héloïse Frison, MSc., Mark D. Minden, MD PhD, Isabelle Laverdiere, BPharm, MSc, PhD, Kolja Eppert, MSc, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5052.
https://doi.org/10.1182/blood-2019-125338
Published: 2019
Journal Articles

Isolation of CD34 − and CD34 + Leukemia Stem Cells from Acute Myeloid Leukemia Blasts Using CD200

Jenny M. Ho, MD, Stephanie M. Dobson, PhD, Jessica McLeod, BSc, Veronique Voisin, PhD, Alex Murison, James Kennedy, MD PhD, Sasan Zandi, MD PhD, Kolja Eppert, MSc, PhD, Mark D. Minden, MD PhD, Mathieu Lupien, John E. Dick, PhD, Jean C.Y. Wang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2790.
https://doi.org/10.1182/blood-2018-99-119318
Published: 2018
Journal Articles

Leukemic Stem Cell Expression Signatures Identify Novel Therapeutics for Acute Myeloid Leukemia

Meaghan Boileau, BSc, Isabelle Laverdiere, BPharm, MSc, PhD, Amanda Mitchell, PhD, Stanley W.K. Ng, Jean Wang, MD PhD, Mark D. Minden, MD PhD, John E. Dick, PhD, Kolja Eppert, MSc, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3815.
https://doi.org/10.1182/blood.V130.Suppl_1.3815.3815
Published: 2017
Journal Articles

Leukemic and Normal Stem Cell Transcriptional Signatures Determined by Functional Assays Are Predictive of the Overall Survival of AML Patients.

Kolja Eppert, MSc, PhD, Katsuto Takenaka, MD, Björn Nilsson, M.D., Ph.D., Eric R Lechman, M.Sc., Ph.D., Vicki Ling, MSc, Joseph Beyene, PhD, Angelo J Canty, PhD, Jayne S Danska, PhD, Mark D Minden, MD, Todd R. Golub, MD, Benjamin L Ebert, MD, PhD, John E Dick, PhD
Journal: Blood
Blood (2009) 114 (22): 389.
https://doi.org/10.1182/blood.V114.22.389.389
Published: 2009